Article Sidebar
Views pdf: 9
A STUDYING THE ROLE OF 18FDG PET/CT IN THE STAGE DIAGNOSIS OF B-CELL NON-HODGKIN'S LYMPHOMA
Main Article Content
Abstract
Objective: Research the role of 18F-FDG PET/CT in the stage diagnosis of B-cell non-Hodgkin lymphoma. Subject and method: Retrospective study, descriptive analysis on 86 patients B-cell non-Hodgkin's lymphoma who were newly detected taken 18FDG-PET/CT scan at Hanoi Oncology Hospital from January 2018 to December 2022. Results: PET/CT reduced the number of patients from 30.2% to 22.1% in stage I, from 33.7% to 26.8% in stage II and increased from 17.5% to 20.9% in stage III, from 18.6% to 30.2% in stage IV. PET/CT results increased the stage in 21/86 patients, accounting for 24.4%. The rate of patients with increased stage after PET/CT scan of aggressive histopathology group for 25%, higher than indolent histopathology group for 21.4%, this difference is not significant at p > 0.05
Article Details
Keywords
B-cell non-Hodgkin lymphoma, 18FDG-PET/CT, SUVmax
References
2. Phạm Văn Thái, Thiều Thị Hằng, Mai Trọng Khoa và cs (2018). Đánh giá vai trò của 18F-FDG PET/CT trong chẩn đoán giai đoạn bệnh u lympho không Hodgkin. Tạp chí Ung thư học Việt Nam, (5), 75-79.
3. Nguyễn Hữu Thường, Nguyễn Kim Lưu, Nguyễn Hải Nguyễn, Ngô Văn Đàn (2022). Vai trò của 18FDG PET/CT trong đánh giá giai đoạn và đáp ứng điều trị u lympho ác tính không Hodgkin. Tạp chí Y- Dược học Quân sự, (6),107-117.
4. Mai Hồng Sơn, Lê Ngọc Hà (2016). FDG PET/CT trong đánh giá giai đoạn và đáp ứng điều trị u lympho không Hodgkin ngoài hạch. Tạp chí Điện quang Việt Nam, (25), 58-64.
5. Metser U, Prica A, Hodgson DC, et al (2018). Effect of PET/CT on the Management and Outcomes of Participants with Hodgkin and Aggressive Non-Hodgkin Lymphoma: A Multicenter Registry. Radiology. Published online December 4, 2018. doi: 10.1148/radiol. 2018181519
6. Raanani P, Shasha Y, Perry C, et al (2006). Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era? Annals of Oncology, 17(1):117-122.
7. Barrington SF, Kirkwood AA, Franceschetto A, et al (2016). PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study. Blood, 127(12):1531-1538.
8. Adams HJA, Kwee TC, de Keizer B, Fijnheer R, de Klerk JMH, Nievelstein RAJ (2014). FDG PET/CT for the detection of bone marrow involvement in diffuse large B-cell lymphoma: systematic review and meta-analysis. Eur J Nucl Med Mol Imaging, 41(3):565-574.
9. Berthet L, Cochet A, Kanoun S, et al (2013). In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy. J Nucl Med, 54(8):1244-1250.